Healthcare & Pharma · NSE / BSE
RapidCare Health Sciences is a multi-specialty diagnostics and healthcare delivery company operating 480+ diagnostic centres across 62 cities in India.
Price Band
₹295 – ₹310
Issue Size
₹1200 Cr
Lot Size
48 shares
GMP
Est. Listing
₹310
at current GMP
Subscribed
42.80x
overall
Open
3 Sep 2026
Close
5 Sep 2026
Allotment
8 Sep 2026
Refund
9 Sep 2026
Demat Credit
9 Sep 2026
Listing
10 Sep 2026
Last updated: 10 Sept 2026
Current Premium
Issue Price (Upper)
₹310
Band: ₹295 – ₹310
Estimated Listing Price
₹310
Upper price + GMP
Lot Size
48 shares
Min investment ₹14,880
Estimated Profit / Lot
₹0
48 × ₹0
Grey Market Premium trend
—
▼ 55 today
Updated 25 days ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 10 Sep 2026 | — | 0.0% | ₹310 |
| 8 Sep 2026 | +₹55 | 17.7% | ₹365 |
| 5 Sep 2026 | +₹75 | 24.2% | ₹385 |
| 3 Sep 2026 | +₹68 | 21.9% | ₹378 |
| 1 Sep 2026 | +₹60 | 19.4% | ₹370 |
| 25 Aug 2026 | +₹52 | 16.8% | ₹362 |
| 20 Aug 2026 | +₹40 | 12.9% | ₹350 |
GMP is unofficial market data. Not a guarantee of listing performance.
RapidCare Health Sciences Limited is bringing an initial public offering (IPO) in the Healthcare & Pharma sector with an aggregate issue size of ₹1,200 Crores. The shares are offered at a price band of ₹295 to ₹310 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2026-09-05, the basis of allotment is scheduled to be finalized on 2026-09-08. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Pvt Ltd) or the BSE allotment checking window.
The latest grey market premium for RapidCare Health Sciences Limited IPO is ₹0, which indicates an expected listing price of ₹310.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.